'PhysioDirect' telephone assessment and advice services for physiotherapy: protocol for a pragmatic randomised controlled trial
1 Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, 25/27 Belgrave Road, Bristol, BS8 2AA, UK
2 Arthritis Research Campaign National Primary Care Centre, Primary Care Services, Keele University, Keele, Staffordshire, ST5 5BG, UK
3 School of Social Policy, Sociology and Social Research, Cornwallis North East, University of Kent, Canterbury, Kent, CT2 7NF, UK
4 Department of Health Economics, School of Health & Population Sciences, Public Health Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
5 Physiotherapy service, Bristol Community Health Physiotherapy Service, Hampton House, Cotham, Bristol, BS6 6AU, UK
BMC Health Services Research 2009, 9:136 doi:10.1186/1472-6963-9-136Published: 3 August 2009
Providing timely access to physiotherapy has long been a problem for the National Health Service in the United Kingdom. In an attempt to improve access some physiotherapy services have introduced a new treatment pathway known as PhysioDirect. Physiotherapists offer initial assessment and advice by telephone, supported by computerised algorithms, and patients are sent written self-management and exercise advice by post. They are invited for face-to-face treatment only when necessary. Although several such services have been developed, there is no robust evidence regarding clinical and cost-effectiveness, nor the acceptability of PhysioDirect.
This protocol describes a multi-centre pragmatic individually randomised trial, with nested qualitative research. The aim is to determine the effectiveness, cost-effectiveness, and acceptability of PhysioDirect compared with usual models of physiotherapy based on patients going onto a waiting list and receiving face-to-face care. PhysioDirect services will be established in four areas in England. Adult patients in these areas with musculoskeletal problems who refer themselves or are referred by a primary care practitioner for physiotherapy will be invited to participate in the trial. About 1875 consenting patients will be randomised in a 2:1 ratio to PhysioDirect or usual care. Data about outcome measures will be collected at baseline and 6 weeks and 6 months after randomisation. The primary outcome is clinical improvement at 6 months; secondary outcomes include cost, waiting times, time lost from work and usual activities, patient satisfaction and preference. The impact of PhysioDirect on patients in different age-groups and with different conditions will also be examined.
Incremental cost-effectiveness will be assessed in terms of quality adjusted life years in relation to cost.
Qualitative methods will be used to explore factors associated with the success or failure of the service, the acceptability of PhysioDirect to patients and staff, and ways in which the service could be improved.
It is still relatively unusual to evaluate new forms of service delivery using randomised controlled trials. By combining rigorous trial methods with economic analysis of cost-effectiveness and qualitative research this study will provide robust evidence to inform decisions about the widespread introduction of PhysioDirect services.
Current Controlled Trials ISRCTN55666618